Microalgae Market

How big is Microalgae Market in 2026?

USD 1153.7 million in 2026 and USD 1910.1 million by 2036 at a 5.2% CAGR.

Sales in the microalgae market are projected to grow at 5.2% CAGR through 2036, climbing from USD 1096.7 million in 2025 to USD 1153.7 million in 2026 before driving valuation to USD 1,910.1 million by 2036. Higher-value demand centers on biomass and extracts with defined composition for a named commercial formulation. The FSA published its consultation summary in March 2026 for the proposed extension of use of Schizochytrium sp. oil rich in DHA and EPA as a novel food in Great Britain, covering meat analogues and fish analogues, with the FSA recommending authorization subject to ministerial decision. Formulators evaluate the authorized oil against strain-specific use conditions during commercial qualification. Suppliers earn recurring revenue by matching composition records and permitted uses to the finished formulation.

National rules are shaping how familiar species and health-oriented microalgae ingredients enter regulated nutrition channels. South Korea is projected to expand at 5.9% CAGR compared with 3.8% for the UK between 2026 and 2036. In March 2025 the Korean Ministry of Food and Drug Safety reset the daily intake for chlorella under national health-functional-food standards. The same revision added intake precautions that affect how selected functional ingredients are documented for sale. Domestic buyers now screen familiar microalgae ingredients against defined national requirements.

Key Takeaways of Microalgae Market

• Demand is rising for microalgae ingredients with documented functional composition and recognized food, nutrition or feed uses.
• Spirulina is projected to hold 38.8% of species type demand in 2026, attributable to established cultivation for repeat biomass and pigment purchasing.
• Fresh water is set to lead the source category with 78.2% share in 2026, supported by established Spirulina and Chlorella cultivation routes.
• Health and medical is likely to capture 42.5% of end use application demand in 2026, influenced by concentrated ingredients used in specialized nutrition.
• Species-specific approvals and contaminant controls are extending qualification time for suppliers that lack consistent identity and batch records.
• Some of the key players in this market include Corbion N.V., DIC Corporation (Earthrise Nutritionals LLC), Cyanotech Corporation, Roquette Frères, Solabia Group (Solabia-Algatech Nutrition), Oterra A/S, BASF SE, Fuqing King Dnarmsa Spirulina Co., Ltd., Yunnan Green A Biological Project Co., Ltd., and Cellana Inc..

Analyst Perspective

“Microalgae ingredients earn repeat orders from suppliers that hold composition steady for each formulation and regulatory route. Commercial advantage comes from controlled cultivation and application evidence rather than undifferentiated biomass.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Microalgae Market segmented?

Species Type, Source and End Use Application define the market segmentation framework.

Species type covers Spirulina, Chlorella, Haematococcus, Dunaliella, Nannochloropsis, Others, Aphanizomenon and Nostoc. Source includes fresh water and marine water. End use application covers health and medical, nutraceuticals & dietary supplements, pharmaceuticals, food and beverage, animal feed, cosmetics, bakery & confectionery and pet food.

How does Spirulina reduce qualification friction within the species type category?

Spirulina supports commercial formats from dried biomass to phycocyanin and retains a familiar identity in food-color and nutrition standards. Japan’s 10th food-additive compendium includes Spirulina Color with defined identity requirements and a specified color-value test for qualified use. The national specification reduces basic uncertainty before a buyer evaluates purity and color performance inside the intended formulation. Food manufacturers compare suppliers on reproducibility instead of rebuilding identity tests for every purchase. The same cultivation base supports spirulina powder applications that require consistent composition and processing for repeat volume.

• Spirulina is projected to hold 38.8% of species type demand in 2026, driven by established cultivation for biomass and pigment ingredients.
• Food and supplement formulators compare identity, color strength and contaminant controls against a known specification during repeat-volume approval.

Why do established cultured species favor fresh water sourcing decisions?

Commercial Spirulina and chlorella ingredients make fresh-water cultivation a routine supply route for nutrition buyers. Cyanotech reported fiscal 2025 bulk Spirulina sales increased 53% and bulk astaxanthin sales increased 73.9%. Those results document active commercial turnover in cultivated microalgae ingredients built on controlled biomass production. Water quality and contaminant controls remain part of supplier qualification because cultivation conditions can alter biomass consistency before drying. Drying performance also determines whether fresh-water biomass moves from trial material into scheduled commercial supply.

• Fresh water is expected to lead the source category with 78.2% share in 2026, supported by commercially mature Spirulina and Chlorella production.
• Repeat orders depend on water quality, contaminant testing and drying controls that preserve identity during cultivation and processing.

What gives health and medical applications a larger share of microalgae value?

Health-oriented applications pay for a defined nutrient or pigment concentration instead of dry biomass volume alone. An August 2026 FSA and FSS assessment found DHA-rich oil from Schizochytrium limacinum ATCC 20889 safe under proposed infant-formula and follow-on-formula conditions. The assessment ties strain identity and product specification directly to the intended regulated nutrition use. Formulators evaluate algae oil ingredients by strain identity and documented composition during regulated nutrition qualification. Concentrated nutrition formats earn more value because the exact ingredient form must meet safety and stability requirements.

• Health and medical is forecast to represent 42.5% of end use application demand in 2026, shaped by concentrated functional ingredients used in specialized nutrition.
• Formulators require evidence that a specific strain and ingredient form meets the safety, composition and stability conditions of the intended application.

What are the drivers, restraints and opportunities in the Microalgae Market?

Functional ingredients expand demand, qualification rules constrain conversion and application-ready extracts create higher-value commercial routes.

• Driver: Defined omega-3, pigment and protein functions move microalgae from generic biomass into qualified formulation inputs.
• Restraint: Species classification and contaminant requirements can delay approval when documentation does not match the intended use.
• Opportunity: Suppliers can earn more value by pairing standardized extracts with formulation support for specific food and nutrition applications.

Defined Functional Concentration Supports Qualified Ingredient Purchasing

Functional concentration is expanding purchasing because microalgae ingredients solve measurable formulation problems within qualified uses. Corbion announced a US patent in April 2026 for a DHA-rich algal biomass suspension designed for feed applications. The protected format addresses stability and handling requirements that buyers evaluate before adding an ingredient to a recurring formula. The same qualification applies to algae protein ingredients because routine production must preserve composition. Suppliers with documented nutrient concentration and processing behavior can enter specifications that are harder to replace on price alone. Feed formulators require application evidence before a technical function becomes scheduled commercial volume.

Classification and Contaminant Requirements Extend Supplier Qualification

Regulatory classification is slowing commercial conversion for species with established food and nutrition histories. Germany’s BVL published an English List of Algae in February 2025 to help classify algae as food ingredients and distinguish them from medicinal products. Intended use changes the applicable route for astaxanthin ingredients and other concentrated extracts sold with specific claims. Suppliers face additional testing and dossier work if composition moves beyond a familiar food use or claim. Classification uncertainty raises qualification costs before a buyer approves recurring orders. Clear species status reduces that burden for proposed uses within the documented regulatory category.

Application-Ready Extracts Increase Value per Qualified Ingredient

Standardized extracts are raising revenue potential by removing preparation work from a customer’s formulation process and arriving with defined performance data. Oterra introduced Arctic Blue with VAXA Technologies in January 2025 using Spirulina cultivated in Iceland for food and beverage coloring. The product converts microalgae biomass into an application-ready ingredient with a defined color function and controlled cultivation route. Oterra’s Spirulina route gives suppliers access to natural food colors that food manufacturers can evaluate before scale-up. Stable concentration and format shorten trial work between production lots. Suppliers that pair standardized extracts with application support can earn more value from each qualified ingredient route.

Which country CAGRs are profiled in the Microalgae Market?

Country	CAGR
USA	6.3%
South Korea	5.9%
Germany	4.6%
Japan	4.2%
UK	3.8%

How do country-level CAGRs compare in the Microalgae Market?

The profiled rates split into two higher entries and a lower cluster of three ranging from 4.6% to 3.8%. The 2.5 percentage-point span measures forecast pace rather than current country size, reflecting that national qualification routes begin from different commercial bases.

• USA growth reflects broader food-color use options for Spirulina extracts alongside domestic ingredient production and stricter specification controls.
• South Korea uses a defined health-functional-food route that makes ingredient documentation central to repeat microalgae purchasing.
• Germany places greater weight on classifying algae correctly before a food ingredient moves into a recurring commercial formulation.
• Japan combines established additive specifications with application testing that keeps identity and color performance visible during supplier selection.
• UK growth depends on product-specific novel-food decisions that can open a defined use without generalizing approval to every strain.

Comparable CAGRs can still produce different entry conditions because each country applies its own qualification sequence and commercial use mix. The full report provides country-level CAGR analysis across North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.

Country-wise Analysis

• The USA combines domestic cultivation with a federal color-additive route that widens food applications for Spirulina extracts. Microalgae Demand in the USA is forecast to rise at 6.3% CAGR over the forecast period, underpinned by additional food color formulations under a defined federal framework. FDA expanded approved Spirulina extract uses in February 2026 and revised several heavy-metal specifications. The agency delayed the effective date in March 2026 while it reviewed objections to the final order. Suppliers align launch timing with the final regulatory schedule and tighter specifications. Domestic production supports availability but use-specific compliance still governs recurring food-color orders.
• South Korea regulates health-functional ingredients through a national standards system that directly affects familiar microalgae products. South Korea’s microalgae outlook is anticipated to advance at 5.9% CAGR over the assessment period, tied to repeat demand in regulated nutrition channels. MFDS updated the Health Functional Food Code in June 2026 and strengthened management specifications for functional ingredients. The same compliance setting applies to microalgae biomass sold for defined health functions within national nutrition channels. Suppliers maintain composition and labeling records that match Korean ingredient standards during repeat account qualification. Consistent testing determines whether familiar microalgae ingredients move from approved specifications into routine purchasing.
• Germany uses a formal algae-classification process before suppliers position an ingredient for a particular food use. Germany is estimated to post 4.6% CAGR over the forecast period, influenced by clearer classification for established species. BVL published an English version of its List of Algae in February 2025 to support food-ingredient classification and the distinction from medicinal products. National guidance is especially relevant to carotenoid ingredients and concentrated extracts sold with explicit use claims. Suppliers align species status with intended use before technical performance converts into recurring food orders. Classification clarity lowers uncertainty but does not replace product-specific composition and claim controls.
• Japan defines Spirulina Color within national food-additive standards and ties the material to identity and performance requirements. Microalgae sales in Japan are set to scale at 4.2% CAGR by 2036, reinforced by familiar additive specifications and established screening. Japan’s Consumer Affairs Agency added an English version of the 10th food-additive compendium in February 2025. The compendium includes the Spirulina Color specification used for phycocyanin formats in qualified applications. Commercial conversion depends on purity and color behavior during routine finished-product manufacturing. Regulatory familiarity clears the first screening step and moves supplier competition toward reproducibility during application testing.
• UK microalgae demand operates under strain-specific novel-food assessments that keep product scope narrow during authorization. The UK microalgae sector is projected to record 3.8% CAGR during the assessment period, shaped by a safety review route for differentiated oils. FSA and FSS published an August 2026 assessment for DHA-rich Schizochytrium limacinum oil intended for infant and follow-on formula. The agencies concluded that the ingredient was safe under the proposed infant-formula and follow-on-formula conditions. The authorization route does not make one strain transferable to unrelated microalgae ingredients.

Who are the notable companies in the Microalgae Market?

Corbion N.V., DIC Corporation (Earthrise Nutritionals LLC), Cyanotech Corporation, Roquette Frères, Solabia Group (Solabia-Algatech Nutrition), Oterra A/S, BASF SE, Fuqing King Dnarmsa Spirulina Co., Ltd., Yunnan Green A Biological Project Co., Ltd., and Cellana Inc. are notable companies active within the defined market.

Competition is divided between integrated cultivators, fermentation-based omega-3 suppliers and specialists that concentrate pigments or other active ingredients. A separate buying route is emerging in microalgae pet nutrition because DHA and whole-algae formats require different nutrition specifications. Entry becomes harder when cultivation control must be combined with food-grade documentation and application support. Competitors therefore differentiate through route-specific capability within qualified ingredient applications instead of corporate scale alone.

• Corbion N.V., DIC Corporation (Earthrise Nutritionals LLC), Cyanotech Corporation and Cellana Inc. operate cultivation or fermentation platforms tied to nutrition ingredients.
• Solabia Group (Solabia-Algatech Nutrition), Oterra A/S and BASF SE focus on differentiated carotenoid or natural-color ingredient routes.
• Roquette Frères, Fuqing King Dnarmsa Spirulina Co., Ltd. and Yunnan Green A Biological Project Co., Ltd. participate through nutrition ingredients or microalgae processing capabilities.

Competitive Benchmarking: Microalgae Market

Company	Cultivation Integration	Specialty Ingredient Capability	Application Breadth	Geographic Reach
Corbion N.V.	High	High	High	Global
DIC Corporation (Earthrise Nutritionals LLC)	High	High	High	Japan, USA and international DIC channels
Cyanotech Corporation	High	High	Medium	USA production with international sales
Roquette Frères	Low	Medium	Medium	Europe with international nutrition channels
Solabia Group (Solabia-Algatech Nutrition)	High	High	High	Israel production with international nutrition sales
Oterra A/S	Low	High	Medium	Europe, North America and Asia-Pacific color channels
BASF SE	Low	Medium	Medium	Global nutrition network
Fuqing King Dnarmsa Spirulina Co., Ltd.	High	High	Medium	China production with export activity
Yunnan Green A Biological Project Co., Ltd.	Medium	High	Medium	China-based production and ingredient activity
Cellana Inc.	High	High	High	USA-based platform with nutrition expansion

Scoring basis: High cultivation integration requires documented owned or tightly integrated microalgae production and multiple processing stages. Medium reflects narrower production control while Low reflects sourcing without comparable control over cultivation and processing. High specialty capability requires multiple differentiated in-scope ingredient formats while Medium requires one documented specialized class. High application breadth requires at least three in-scope end-use groups while Medium requires two and Low identifies one verified group.

Key Developments in the Microalgae Market

• In July 2026, Oterra A/S launched liquid versions of Arctic Blue and Jungle Blue for food and beverage applications with Arctic Blue derived from Spirulina.
• In July 2025, Corbion N.V. secured Chinese registrations and licenses for AlgaVia DHA and AlgaPrime DHA to serve human and animal nutrition applications.
• In March 2025, DIC Corporation subsidiary Earthrise Nutritionals LLC began operating a California edible-algae cultivation facility built for controlled Spirulina production.

Key Players in the Microalgae Market

Integrated cultivation and omega-3 platforms

• Corbion N.V.
• DIC Corporation (Earthrise Nutritionals LLC)
• Cyanotech Corporation
• Cellana Inc.

Specialty carotenoid and natural-color suppliers

• Solabia Group (Solabia-Algatech Nutrition)
• Oterra A/S
• BASF SE

Nutrition ingredient and processing specialists

• Roquette Frères
• Fuqing King Dnarmsa Spirulina Co., Ltd.
• Yunnan Green A Biological Project Co., Ltd.

Microalgae Market - Report Scope

Coverage field	Report scope
Market breakdown	By species type, source, end use application and region.
Quantitative Units	Revenue in USD million and CAGR in %.
Market Definition	Commercial microalgae biomass and microalgae-derived ingredient forms sold within the stated species, source and application taxonomy. Downstream finished-product revenue, macroalgae and unrelated services are excluded.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	USA, South Korea, Germany, Japan, UK, and 20+ countries included in the full report.
Key Companies Profiled	Corbion N.V., DIC Corporation (Earthrise Nutritionals LLC), Cyanotech Corporation, Roquette Frères, Solabia Group (Solabia-Algatech Nutrition), Oterra A/S, BASF SE, Fuqing King Dnarmsa Spirulina Co., Ltd., Yunnan Green A Biological Project Co., Ltd., and Cellana Inc..
Forecast Period	2026 to 2036.
Approach	Primary and secondary research with market triangulation.

Microalgae Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Microalgae Market by Segments

Microalgae Market segmented by Species Type:

• Spirulina
• Chlorella
• Haematococcus
• Dunaliella
• Nannochloropsis
• Others
• Aphanizomenon
• Nostoc

Microalgae Market segmented by Source:

• Fresh Water
• Marine Water

Microalgae Market segmented by End Use Application:

• Health and Medical
• Nutraceuticals & Dietary Supplements
• Pharmaceuticals
• Food and Beverage
• Animal Feed
• Cosmetics
• Bakery & Confectionery
• Pet Food

Microalgae Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France
  • Nordics
  • Benelux
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan and Baltic States
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union Countries
  • Rest of Middle East and Africa

Research Sources and Bibliography

• STAR-K Kosher Certification. (2025, August 27). Fuqing King Dnarmsa Spirulina Co., Ltd.
• Cyanotech Corporation. (n.d.). Our Purpose. Retrieved September 17, 2026.
• Corbion. (2026, June 22). Corbion reports significant improvements in updated life cycle assessment of algae-derived omega-3 DHA.
• Corbion. (2025, August 19). Corbion and Kuehnle AgroSystems join forces to develop natural Astaxanthin from algae fermentation.
• Cyanotech Corporation. (2025, November 10). Cyanotech Reports Financial Results for the Second Quarter of Fiscal 2026.
• DIC Corporation. (2026, February 18). LINABLUE® Wonder-Delivering Safe, Reliable, Consistent Natural Blue Food Colorant Phycocyanin, Extracted from Spirulina Edible Blue-Green Algae, Cultivated Using More Sustainable Smart Farming Technologies.
• Roquette Frères. (n.d.). Our solutions for Pet Food. Retrieved September 17, 2026.
• Cellana / PhytoSmart. (n.d.). Cellana and PhytoSmart Unite to Build a Stronger, Broader Algae Platform. Retrieved September 17, 2026.
• Yunnan Green A Biological Project Co., Ltd. (n.d.). Retrieved September 17, 2026.
• China Food Additives and Ingredients Association. (n.d.). Fuqing King Dnarmsa Spirulina Co., Ltd. Retrieved September 17, 2026.
• BASF Japan Ltd. (2025, March). Main Product List.
• Oterra. (n.d.). Discover Arctic Blue. Retrieved September 17, 2026.
• Solabia. (n.d.). Our Know-How. Retrieved September 17, 2026.
• Solabia. (2026, June). RAPPORT RSE.
• DIC Corporation. (2026, June 30). Principal Subsidiaries and Affiliates outside Japan.
• DIC Corporation. (2025, April 14). DIC Subsidiary in the United States Opens New Facility for Cultivating Edible Algae with the Goal of Realizing Sustainable Smart Farming.
• Corbion. (2025, July 8). Corbion secures multiple regulatory approvals in China for algae-derived omega-3 solutions.
• Oterra. (2026, July 7). Oterra launches liquid natural blue colors to give food and beverage brands a broader, brighter choice.
• Ministry of Food and Drug Safety, Republic of Korea. (2026, June 11).
• USA Food and Drug Administration. (2026, February 6). Listing of Color Additives Exempt From Certification; Spirulina Extract.
• Oterra. (2025, January 15). High-tech partnership creates a natural blue color for a greener tomorrow.
• Federal Office of Consumer Protection and Food Safety, Germany. (2025, February 13). English version of the List of Algae and the 3rd edition of the Preface to the Lists of Substances published.
• Corbion. (2026, April 20). Corbion advances algae innovation with new US patent for omega-3 fatty acids derived from algae.
• Food Standards Agency & Food Standards Scotland. (2026, August 6). Assessment on the Safety of DHA-rich Algal Oil From Schizochytrium Limacinum Strain ATCC 20889 for Use in Infant Formula and Follow-On Formula (RP2358).
• Cyanotech Corporation. (2025, June 20). Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025.
• Consumer Affairs Agency, Japan. (2025, February 5). [10th Edition of Japan's Specifications and Standards for Food Additives].
• Ministry of Food and Drug Safety, Republic of Korea. (2025, March 5).
• Food Standards Agency. (2026, March 24). Schizochytrium sp. oil rich in DHA and EPA.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the microalgae market in 2026 and 2036?
• Which operating conditions convert microalgae functionality into recurring ingredient demand?
• Why does Spirulina account for 38.8% of species type demand?
• Why does fresh water account for 78.2% of source demand?
• Which end use application accounts for 42.5% of microalgae demand in 2026?
• How do the five profiled country growth rates differ through 2036?
• Which companies compete through cultivation, omega-3 ingredients or natural colors?
• What limits broader qualification of microalgae ingredients in regulated applications?
• Which buyer checks determine whether microalgae trials become repeat orders?